Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06199713
What this trial is testing

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
University of Wisconsin, Madison 24
Testing effectiveness (Phase 2)UnknownNCT06566391
What this trial is testing

Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma

Who this might be right for
Melanoma
European Institute of Oncology 35
Testing effectiveness (Phase 2)UnknownNCT04017897
What this trial is testing

The Combination of Anti-PD-1 With Radiotherapy in Previously Untreated Metastatic Melanoma

Who this might be right for
Melanoma
Yonsei University 52
Early research (Phase 1)Ended earlyNCT00758797
What this trial is testing

A Novel Treatment for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Northwestern University 7
Testing effectiveness (Phase 2)Ended earlyNCT00505635
What this trial is testing

Biochemotherapy With Temozolomide for Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 5
Very early researchStudy completedNCT05704933
What this trial is testing

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Who this might be right for
Metastatic MelanomaMetastasis to Brain
H. Lee Moffitt Cancer Center and Research Institute 1
Testing effectiveness (Phase 2)Ended earlyNCT02771626
What this trial is testing

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Calithera Biosciences, Inc 118
Testing effectiveness (Phase 2)Study completedNCT00514085
What this trial is testing

Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)WithdrawnNCT03126461
What this trial is testing

SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients

Who this might be right for
MelanomaMetastatic Melanoma
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT02126579
What this trial is testing

Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists

Who this might be right for
MelanomaMetastatic MelanomaMucosal Melanoma
Craig L Slingluff, Jr 50
Testing effectiveness (Phase 2)Study completedNCT01099514
What this trial is testing

Study of Nilotinib in Metastatic Melanoma With KIT Aberrations

Who this might be right for
Metastatic Melanoma With KIT Aberration
Samsung Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT01335009
What this trial is testing

Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Eisai Inc. 76
Testing effectiveness (Phase 2)Ended earlyNCT01543464
What this trial is testing

Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients

Who this might be right for
Malignant Melanoma
Inge Marie Svane 41
Not applicableLooking for participantsNCT06488365
What this trial is testing

In Vivo Liquid Biopsy of Melanoma (Cytophone)

Who this might be right for
MelanomaCirculating Tumor CellsMetastatic Melanoma+1 more
Cytoastra 180
Early research (Phase 1)Ended earlyNCT01123304
What this trial is testing

Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma

Who this might be right for
Melanoma
Morphotek 18
Early research (Phase 1)Study completedNCT00412581
What this trial is testing

Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00082914
What this trial is testing

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Testing effectiveness (Phase 2)Study completedNCT02363283
What this trial is testing

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

Who this might be right for
Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00185302
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Who this might be right for
Melanoma
Bayer 28
Next Page